Sponsor or institution
Clinical trials and research at Edgewood Oncology Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Edgewood Oncology Inc. that are recruiting, in United States. By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Evaluating BTX-A51 for advanced solid tumors and breast cancer
This study is testing a new treatment called BTX-A51 for people with advanced solid tumors and metastatic breast cancer to see how safe it is and if it works better alone or with another medication.
-
Evaluating BTX-A51 for patients with relapsed or refractory acute myeloid leukemia or high-risk myelodysplastic syndrome
This study is testing a new drug called BTX-A51 to see if it can help people with relapsed or hard-to-treat acute myeloid leukemia or high-risk myelodysplastic syndrome feel better and improve their treatment options.
Quick answers
How many clinical trials run by Edgewood Oncology Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.